Nelson Sun has bought AARD on 3 days since Feb 2025

Nelson Sun is the Chief Financial Officer (CFO) of Aardvark Therapeutics, Inc. (NASDAQ: AARD), a biopharmaceutical company developing therapies for metabolic and inflammatory diseases.( He recently purchased 3,000 shares of AARD on December 11, 2025, at $14.4 per share, totaling $43,200, bringing his direct ownership to 108,484 shares.(

Sun brings over 20 years of experience in financial management, business operations, and corporate strategy.( Prior to Aardvark, he served as Operating Partner at Dubilier & Company, assessing underperforming assets and providing executive oversight to portfolio companies, and as Vice President at Valor Equity Partners, focusing on M&A, portfolio management, and operations.( Earlier roles include Vice President and Counsel at NantWorks and Abraxis BioScience, and Counsel, Corporate Development at American Pharmaceutical Partners.( He holds an MBA in Finance from The Wharton School and an MA in International Studies from the University of Pennsylvania.(

Written by Perplexity from public sources.